Document Detail


PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
MedLine Citation:
PMID:  11154988     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The case of an adult with PML/RARalpha(+) hypergranular acute promyelocytic leukemia (M3) that evolved into a rapidly fatal M3 acute myelocytic leukemia without PML/RARalpha after a complete and molecular remission had been achieved, is presented. Only 7 such cases have been published in the literature. The possible origin of this either leukemic relapse or secondary malignancy is briefly discussed, focusing on the fact that this diagnosis could only be defined by adequate molecular biology studies in the leukemic cells.
Authors:
G J Ruiz-Argüelles; G J Ruiz-Delgado; V Reyes-Núñez
Related Documents :
24801068 - Wine and headache.
10651118 - Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report.
16545708 - A trifungal infection of the mandible: case report and literature review.
8629448 - Acute myelofibrosis in children: report on two cases.
24959368 - Papillary-cystic variant of acinic cell carcinoma in the lacrimal gland.
9135828 - Cardiac tamponade.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta haematologica     Volume:  104     ISSN:  0001-5792     ISO Abbreviation:  Acta Haematol.     Publication Date:  2000  
Date Detail:
Created Date:  2001-01-26     Completed Date:  2001-03-01     Revised Date:  2006-09-29    
Medline Journal Info:
Nlm Unique ID:  0141053     Medline TA:  Acta Haematol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  124-7     Citation Subset:  IM    
Affiliation:
Centro de Hematología y Medicina Interna de Puebla, Universidad La Salle, México, México. gruiz1@prodigy.net.mx
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Humans
Leukemia, Promyelocytic, Acute / drug therapy,  genetics*,  pathology*
Male
Neoplasm Proteins / biosynthesis*,  genetics
Oncogene Proteins, Fusion / biosynthesis*,  genetics
Pancytopenia / genetics,  pathology
Receptors, Retinoic Acid / genetics*
Recurrence
Reverse Transcriptase Polymerase Chain Reaction
Tretinoin / therapeutic use
Chemical
Reg. No./Substance:
0/Neoplasm Proteins; 0/Oncogene Proteins, Fusion; 0/Receptors, Retinoic Acid; 0/promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; 0/retinoic acid receptor alpha; 302-79-4/Tretinoin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myelodysplastic syndrome with clonal eosinophilia accompanied by eosinophilic pulmonary interstitial...
Next Document:  Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refract...